Meningococcal Conjugate Vaccine

Generic Name

Meningococcal Conjugate Vaccine

Other Names

• MCV

Drug Class

• Vaccine

Chemical Formula

Molecular Weight

Mechanism of Action

• Induces active immunity against meningococcal bacteria

Indications

• Prevention of invasive meningococcal disease caused by Neisseria meningitidis

Common Dosage Forms

• Injection

Typical Dosage

• Booster dose at specific intervals based on age and risk factors

Pediatric Dosage

• Doses vary based on age and brand of the vaccine

Geriatric Dosage

• Similar to adult dosage

Side Effects

• Pain or redness at injection site
• Fever
• Headache
• Fatigue

Contraindications

• Severe allergic reaction to a previous dose of the vaccine or any component

Pregnancy Category

• Generally considered safe during pregnancy if the benefits outweigh the risks

Lactation Safety

• Considered safe during breastfeeding

Drug Interactions

• No significant drug interactions reported

Overdose Symptoms

• Unlikely in a clinical setting

Antidote for Overdose

• N/A

Storage Conditions

• Store in the refrigerator, do not freeze

Pharmacokinetics

• Absorption: Well absorbed after intramuscular injection
• Distribution: Not specified
• Metabolism: Not specified
• Excretion: Not specified

Precautions

• History of Guillain-Barre syndrome

Warnings

• May not provide 100% protection against all meningococcal serogroups

Others

• Multiple doses or booster shots may be required for long-term protection